Lilly's weight loss drug cuts diabetes risk by 94% in three-year trial, company says - NBC News

on
* Lilly's weight loss drug cuts diabetes risk by 94% in three-year trial, company says  NBC News
* Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial  CNBC
* Lilly's Weight-Loss Shot Zepbound Cuts Diabetes Risk, Study Says  Bloomberg
* Tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says  CNN
* Eli Lilly's weight loss drug almost eliminates the risk of diabetes in overweight adults  Quartz


http://dlvr.it/TC8L7v

Comments

Post a Comment